Saturday, September 25, 2010 4:34:04 PM
If we could pick up some interest from a big cosmetics company, that would definitely help with the cash flow in the short run, while we wait for STOP TBI II-B results to come in.
Agreed, unanimous approval from the safety committee for the first cohort is very good news. I'm surprised PPS hasn't picked up, but then again, our economy is at the worst point it's been in decades. Imagine a bullish market?
Agreed, unanimous approval from the safety committee for the first cohort is very good news. I'm surprised PPS hasn't picked up, but then again, our economy is at the worst point it's been in decades. Imagine a bullish market?
Recent TENX News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/22/2026 12:21:35 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 12:19:57 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/22/2026 12:17:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2026 12:00:16 PM
- Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer • GlobeNewswire Inc. • 04/22/2026 11:00:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/08/2026 10:26:03 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/24/2026 03:41:34 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/10/2026 11:48:55 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2026 11:32:44 AM
- Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/10/2026 11:00:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/09/2026 04:24:22 PM
- Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference • GlobeNewswire Inc. • 03/03/2026 12:00:00 PM
- Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026 • GlobeNewswire Inc. • 02/04/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 02:49:18 AM
